These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 22466)
21. Differential effects of acute and chronic beta-adrenoreceptor blockade on blood pressure and the renin-angiotensin-aldosterone system in essential hypertension. Kolloch R; Stumpe KO; Vetter H; Gramann W; Krück F Clin Sci Mol Med Suppl; 1976 Dec; 3():537s-540s. PubMed ID: 799564 [TBL] [Abstract][Full Text] [Related]
22. Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs. Huang X; Li J; Liu L; Chen G; Yi Y; Li P; Wu Y; Xu Y; Bao H; Yu L; Qin X; Zhang Y; Wang B; Li J; Fan Hou F; Huo Y; Cheng X; Spence JD Hypertens Res; 2019 Dec; 42(12):1971-1978. PubMed ID: 31562418 [TBL] [Abstract][Full Text] [Related]
23. [Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)]. Mantero F; Perini A; Armanini D; Gion M; Opocher G; Boscaro M G Ital Cardiol; 1976; 6(7):1246-53. PubMed ID: 1010235 [TBL] [Abstract][Full Text] [Related]
24. [Effect of changes of posture, beta-blocking agents and the cold pressure test on the levels of plasma renin activity (PRA) in essential hypertension with low serum renin]. Del Guercio R; Gentile S; Saponara A; De Buono AF Clin Ter; 1980 Sep; 94(6):627-34. PubMed ID: 6109590 [No Abstract] [Full Text] [Related]
25. Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment. Davidson C; Thadani U; Singleton W; Taylor SH Br Med J; 1976 Jul; 2(6026):7-9. PubMed ID: 7342 [TBL] [Abstract][Full Text] [Related]
26. [Clinical experiences with carteolol in patients with essential hypertension]. Viehmann P Arzneimittelforschung; 1983; 33(2a):322-5. PubMed ID: 6340701 [TBL] [Abstract][Full Text] [Related]
28. A comparative study of the effects of oxprenolol versus propranolol in essential hypertension. Gavras I; Gavras H; Sullivan PC; Tifft CP; Chobanian AV; Brunner HR J Clin Pharmacol; 1979 Jan; 19(1):8-14. PubMed ID: 368088 [No Abstract] [Full Text] [Related]
29. [Long-term administration of trimepranol in young men with labile borderline hypertension and its influence on plasma renin activity (author's transl)]. Slabý A; Dosková M; Jirák R; Pavlát J; Urbánek J; Reisenauer R Sb Lek; 1975 Apr; 77(4):107-11. PubMed ID: 238278 [No Abstract] [Full Text] [Related]
30. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension. Yamamoto Y Jpn Heart J; 1975 Jul; 16(4):404-20. PubMed ID: 1152295 [TBL] [Abstract][Full Text] [Related]
31. Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure. Stumpe KO; Kolloch R; Vetter H; Gramann W; Krück F; Ressel C; Higuchi M Am J Med; 1976 May; 60(6):853-65. PubMed ID: 14499 [TBL] [Abstract][Full Text] [Related]
32. Renin and age as determinants of a predominantly betablocker-based antihypertensive drug program. Bühler FR; Lütold BE Adv Nephrol Necker Hosp; 1976; 6():303-17. PubMed ID: 14485 [TBL] [Abstract][Full Text] [Related]
33. [Effects of beta-blocking agent carteolol on healthy volunteers and glaucoma patients (author's transl)]. Negishi C; Ueda S; Kanai A; Nakajima A; Funahashi M; Kitazawa Y; Komemushi S Nippon Ganka Gakkai Zasshi; 1981 Jan; 85(1):57-66. PubMed ID: 6114632 [No Abstract] [Full Text] [Related]
34. Effects of beta-adrenoreceptor blocking drugs on plasma volume. Renin and aldosterone as components of their antihypertensive action. Gordon RD Drugs; 1976; 11 SUPPL 1():156-63. PubMed ID: 6248 [TBL] [Abstract][Full Text] [Related]
35. Beta adrenergic blockade and diuretic therapy in benign essential hypertension: A dynamic assessment. Davies R; Payne NN; Slater JD Am J Cardiol; 1976 Mar; 37(4):637-41. PubMed ID: 3963 [TBL] [Abstract][Full Text] [Related]
36. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension. Bianchetti MG; Boehringer K; Weidmann P; Link L; Schiffl H; Ziegler WH Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141 [TBL] [Abstract][Full Text] [Related]
37. Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise. Hansson BG; Hökfelt B Eur J Clin Pharmacol; 1975 Oct; 9(1):9-19. PubMed ID: 9298 [TBL] [Abstract][Full Text] [Related]
38. Effects of beta 1-selective and non-selective beta-blockade on blood pressure, plasma renin activity and plasma aldosterone in hypertensive patients. van Herwaarden CL; Fennis JF; van 'T Laar A Neth J Med; 1979; 22(1):17-22. PubMed ID: 368667 [No Abstract] [Full Text] [Related]
39. Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension. Epstein SE; LUbbe WF S Afr Med J; 1977 Nov; 52(22):875-9. PubMed ID: 343273 [TBL] [Abstract][Full Text] [Related]
40. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in pateints with essential hypertension. Thomas GW; Ledingham JG; Beilin LJ; Yeates KM Aust N Z J Med; 1976 Aug; 6(3 Suppl):44-8. PubMed ID: 798576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]